PharmaJet Inc. announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to pursue innovations that address persistent health and development challenges.
Dr. Linda McAllister,... - November 16, 2011
PharmaJet has received two FDA 510(k) marketing clearances for its IM/SC injection technology. Below are the Indications For Use, cleared by the FDA.
FDA 510(k) Number K111517: PharmaJet Stratis Needle-free Injection System:
The PharmaJet Stratis Needle-free Injection System is intended to deliver... - October 25, 2011
Kroger will offer the PharmaJet needle-free injection option at over 800 Kroger and The Little Clinics locations nationwide. - September 23, 2011
Selected by a panel of independent judges, the Entrepreneur of the Year award finalists are chosen based on their extraordinary success, vision and personal commitment to their business and community. - May 25, 2011
First FDA-cleared needle-free injection alternative to needle-based “Mantoux” method. - March 25, 2011
Funding advances development of needle‐free injector that enables reduced doses and antigen‐sparing of vaccines. - February 03, 2011
Searching for for effective methods to deliver DNA vaccines, USAMRIID's experimental vaccine against smallpox will be evaluated in pre-clinical studies utilizing PharmaJet's needle-free injection technology - December 08, 2010
This joint contract with PharmaJet and Inviragen will one day aid in the 30-50 million cases of debilitating dengue fever and 0.5 - 2 million cases of life-threatening dengue hemorrhagic fever every year. - October 13, 2010
(Laureate) is One of 15 Innovators From Around the World Recognized for Applying Technology to Benefit Humanity - October 04, 2010